Delivery device as a booster for Cell & Gene Therapy success
Cell and gene therapy delivery is an emergent and transformative industry.
modular solutions for airless spray device for topical treatment and delivery, adaptable for various drugs.
More abouta platform offering fully automated preparation and reconstitution devices.
More aboutan all-in-one platform offering fully automated preparation and delivery devices.
More aboutEVEON transforms the patient experience with technological, digital and user innovation products and services to improve the handling, preparation (lyo, dilution, liquid-liquid,...) and administration (injection, infusion, spraying, nebulization,...) of specific drugs. Our native digital platform enables tracking and connected features beyond the core disposable fluidic features. We develop and manufacture custom product for pharmaceutical, biotech companies and medical device manufacturers from prototype to production under ISO-13485 standards.
Certified ISO 13485:2016, EVEON designs, develops, produces and distributes custom-made medical devices based on technological building blocks, for preparation and/or delivery of high value products.
Read moreTransforming Patient Experience
Based on more than 7 years of research, EVEON is specialized in preparation and automatic delivery of therapeutic treatments to improve patients’ quality of life. Partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation custom-made products and services.
Cell and gene therapy delivery is an emergent and transformative industry.
EVEON and Sensorion collaborating to develop an injection system for the delivery of gene therapy treatments into the inner ear
EVEON exhibited at Pharmapack - booth F68 and at Innovation Gallery, on February 1-2, 2023 in Paris (France).
Read the latest article published in OnDrugDelivery about the current challenges faced by the topical spray-based delivery of therapeutics. And how our Ad-Mist™ spray nozzle overcomes these challenges to harness the potential of this delivery route.